সংবাদ
The FDA has approved Ekterly (sebetralstat) as the first and only oral on-demand medication for acute attacks of hereditary angioedema (HAE).
J&J is looking to add a hormone-sensitive indication to its prostate cancer therapy, which was originally approved in 2023.
Alembic Pharmaceuticals has acquired UTILITY therapeutics, expanding its portfolio with the addition of Pivya to treat uUTIs.
The DoH and Children’s National Hospital in the US have signed a MoU to advance paediatric cell and gene therapy.
A discussion on formulation development, contract services, and some of the critical considerations when moving from molecule to clinic.
Sanofi's antibody riliprubart has received orphan drug designation from Japan's MHLW for its potential to treat CIDP.
Proposals for drug exclusivities and feeble measures to combat drug shortages are unlikely to boost innovation, say some ...
The approval comes amid speculation that AstraZeneca CEO Pascal Soriot is considering delisting its UK stock market listing for the US.
The U.S. Food and Drug Administration’s (FDA’s) evolving guidance on Computer Software Assurance and AI/ML-Based Software ...
Biocon Biologics’ Denosumab biosimilars, Vevzuo and Evfraxy, have received marketing authorisation in the European Union (EU).
The FDA has approved Takeda’s new immunoglobulin therapy, Gammagard liquid ERC [immune globulin infusion (human)], to treat ...
The sale caps a difficult time for zilovertamab and ONCT-808 under Oncternal’s ownership. Zilovertamab was deprioritised by ...
কিছু ফলাফল লুকানো হয়েছে কারণ সেগুলি আপনার কাছে অগম্য হতে পারে।
অগম্য ফলাফলসমূহ দেখান